The leptin receptor (OB-R) is a key component in the regulation of body weight and energy homeostasis. The ob/ob and db/db mice were among the first genetic models studied for obesity, with ob/ob mice lacking the leptin hormone and db/db mice showing resistance to its effects. The leptin gene was identified through genetic cloning, and its product, leptin, is produced in adipose tissue and circulates in the blood. Leptin acts as an "adipostat," signaling the body's energy storage status to regulate appetite, metabolism, and nutrient partitioning. Leptin levels increase with body fat and decrease during weight loss, suggesting that leptin resistance, rather than deficiency, may be more prevalent in human obesity. The leptin receptor was cloned using expression cloning techniques, revealing it as a class I cytokine receptor. Multiple forms of the receptor exist, including short and long intracellular domains. The long form (OB-R_L) is believed to be the signaling form, while the short form (OB-R_S) may play roles in transport or clearance. The db/db mouse model is linked to a mutation in the OB-R gene, causing a splicing defect that truncates the long intracellular domain, leading to leptin resistance. The leptin receptor is also involved in the obesity of the fa rat and the Koletsky rat, where mutations in the OB-R gene lead to receptor dysfunction. The signaling pathway of the leptin receptor involves JAK/STAT proteins and may also engage other pathways such as MAPK and PI3K. The long form of the receptor is capable of activating STAT proteins, which translocate to the nucleus and regulate gene expression. The short form may not be as active in signaling. The role of the leptin receptor in the central nervous system is critical, with leptin binding to receptors in the hypothalamus influencing appetite and energy balance. Leptin resistance may occur at various stages, including transport across the blood-brain barrier or at the receptor level. Understanding the signaling pathways and receptor variants of the leptin receptor is crucial for developing therapeutic strategies for obesity and related metabolic disorders.The leptin receptor (OB-R) is a key component in the regulation of body weight and energy homeostasis. The ob/ob and db/db mice were among the first genetic models studied for obesity, with ob/ob mice lacking the leptin hormone and db/db mice showing resistance to its effects. The leptin gene was identified through genetic cloning, and its product, leptin, is produced in adipose tissue and circulates in the blood. Leptin acts as an "adipostat," signaling the body's energy storage status to regulate appetite, metabolism, and nutrient partitioning. Leptin levels increase with body fat and decrease during weight loss, suggesting that leptin resistance, rather than deficiency, may be more prevalent in human obesity. The leptin receptor was cloned using expression cloning techniques, revealing it as a class I cytokine receptor. Multiple forms of the receptor exist, including short and long intracellular domains. The long form (OB-R_L) is believed to be the signaling form, while the short form (OB-R_S) may play roles in transport or clearance. The db/db mouse model is linked to a mutation in the OB-R gene, causing a splicing defect that truncates the long intracellular domain, leading to leptin resistance. The leptin receptor is also involved in the obesity of the fa rat and the Koletsky rat, where mutations in the OB-R gene lead to receptor dysfunction. The signaling pathway of the leptin receptor involves JAK/STAT proteins and may also engage other pathways such as MAPK and PI3K. The long form of the receptor is capable of activating STAT proteins, which translocate to the nucleus and regulate gene expression. The short form may not be as active in signaling. The role of the leptin receptor in the central nervous system is critical, with leptin binding to receptors in the hypothalamus influencing appetite and energy balance. Leptin resistance may occur at various stages, including transport across the blood-brain barrier or at the receptor level. Understanding the signaling pathways and receptor variants of the leptin receptor is crucial for developing therapeutic strategies for obesity and related metabolic disorders.